About
Kadence Bio is a clinical-stage life sciences company developing novel therapeutics targeting sexual and mental health, including the first FDA-approved treatment for premature ejaculation.
Explore Kadence Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.